XOMA royalty-2c.png
XOMA Declares Quarterly Preferred Stock Dividends
March 21, 2024 07:30 ET | XOMA Corporation
April 2024 quarterly dividend
XOMA royalty-2c.png
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
March 08, 2024 07:30 ET | XOMA Corporation
Raised up to $140 million of non-dilutive non-recourse capital through a royalty-backed loan related to VABYSMO® from funds managed by Blue Owl Capital Received $15.5 million in cash payments related...
XOMA royalty-2c.png
XOMA to Present at Upcoming Investor Conferences in March
February 28, 2024 07:30 ET | XOMA Corporation
EMERYVILLE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the following...
XOMA royalty-2c.png
XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
February 16, 2024 08:00 ET | XOMA Corporation
XOMA enters agreement to acquire Kinnate for cash and CVR; Expects to add $9.5M cash to balance sheet upon completion of acquisition
XOMA royalty-2c.png
XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition
January 18, 2024 08:30 ET | XOMA Corporation
XOMA provided an $8 million non-dilutive royalty capital solution to Talphera XOMA will receive a 15% royalty on all commercial sales and a significant portion of the 75% royalty generated by...
XOMA royalty-2c.png
FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx
January 11, 2024 16:05 ET | XOMA Corporation
EMERYVILLE, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today that based upon the U.S. Food and Drug Administration’s (FDA)...
XOMA royalty-2c.png
XOMA Announces Stock Repurchase Program of up to $50 Million
January 02, 2024 07:30 ET | XOMA Corporation
XOMA to repurchase up to $50M of its stock before January 2027. Management actively participating in capital structure to maximize shareholder value.
XOMA royalty-2c.png
XOMA Declares Quarterly Preferred Stock Dividends
December 20, 2023 07:30 ET | XOMA Corporation
January quarterly dividend payment to XOMAP and XOMAO stockholders of record on 1/3/2024